Cargando…
Predicting Survival Across Acute Exacerbation of Interstitial Lung Disease in Patients with Idiopathic Inflammatory Myositis: The GAP-ILD Model
INTRODUCTION: Risk prediction is challenging in patients with idiopathic inflammatory myopathies (IIM) and acute exacerbation of interstitial lung disease (AE-ILD) because of heterogeneity and patient-specific variables. Our objective was to assess whether mortality is accurately predicted in patien...
Autores principales: | Cao, Heng, Huan, Caijuan, Wang, Qin, Xu, Guanhua, Lin, Jin, Zhou, Jianying |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7695794/ https://www.ncbi.nlm.nih.gov/pubmed/33106937 http://dx.doi.org/10.1007/s40744-020-00244-1 |
Ejemplares similares
-
CCL18 as a Biomarker of Interstitial Lung Disease (ILD) and Progressive Fibrosing ILD in Patients with Idiopathic Inflammatory Myopathies
por: Zanatta, Elisabetta, et al.
Publicado: (2023) -
ILD-GAP Combined with the Charlson Comorbidity Index Score (ILD-GAPC) as a Prognostic Prediction Model in Patients with Interstitial Lung Disease
por: Fujii, Hiroaki, et al.
Publicado: (2023) -
Lung transplantation for interstitial lung disease in idiopathic inflammatory myositis: A cohort study
por: Rivière, Amélie, et al.
Publicado: (2022) -
ChILD – Children's interstitial lung disease
Publicado: (2018) -
Significance of Myositis Autoantibody in Patients with Idiopathic Interstitial Lung Disease
por: Song, Ju Sun, et al.
Publicado: (2015)